bremelanotide raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-07-03 and is reviewed periodically as new material appears.
The melanocortin system comprises five G protein-coupled receptors, designated MC1 through MC5, that signal mainly through cyclic AMP accumulation. MC1R and MC2R are associated with pigmentation and adrenal steroid production, while MC3R and MC4R are expressed in the central nervous system and influence energy balance and behavior. MC5R appears in exocrine tissues. Natural agonists include alpha-melanocyte-stimulating hormone and adrenocorticotropic hormone, and endogenous antagonists such as agouti-related protein modulate the same sites. This receptor family provides the framework within which bremelanotide activity is described.
Bremelanotide acts as an agonist at several melanocortin receptors, with the strongest reported activity at MC4R and measurable activity at MC1R and MC3R. Because MC4R is expressed in hypothalamic and limbic circuits, the proposed mechanism links receptor activation to modulation of central pathways involved in desire rather than to direct effects on peripheral genital tissue. The precise downstream steps remain incompletely characterized, and evidence for the involvement of specific neurotransmitters is suggestive rather than settled. Nausea and blood pressure elevation reported during trials are consistent with melanocortin signaling outside the intended target circuit.
Compared with melanotan II, bremelanotide is a smaller cyclic peptide with a more constrained backbone, which affects receptor selectivity and metabolic stability. Published descriptions give a plasma half-life on the order of a few hours after subcutaneous administration, with elimination through hepatic and renal routes and limited plasma protein binding. Central access is inferred from effects observed in animal models, although direct measurement in humans is limited. Handling and storage requirements follow from the peptide backbone, which is susceptible to hydrolysis and oxidation.
Early research on PT-141 grew out of work on melanotan II, a related cyclic peptide studied for pigmentation. Investigators observed that centrally acting melanocortin agonists also influenced sexual behaviour in animal models, and the programme shifted toward that endpoint. A nasal formulation was evaluated in clinical trials but showed inconsistent absorption, and later studies used subcutaneous administration instead. Regulatory approval in the United States followed in 2019 for a defined population of premenopausal women with acquired, generalised hypoactive sexual desire disorder. That approval was specific to that group rather than a broad indication.
Bremelanotide acts as a non-selective agonist at melanocortin receptors, with reported activity at MC1R, MC3R, MC4R and MC5R. The proposed basis for its central effects is activation of MC4R populations in the hypothalamus, a region associated with appetite and reproductive signalling. Because the peptide carries a net positive charge and polar side chains, it does not cross biological membranes freely, which is one reason oral administration is not the standard route. Effects generally appear within an hour of parenteral administration and are described as centrally mediated rather than peripheral.
Bremelanotide, developed under the code PT-141, is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone. Its structure is Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH, with a lactam bridge joining the aspartate and lysine side chains. The molecule has the formula C50H68N14O10 and a monoisotopic mass near 1025 daltons. It is commonly prepared as the acetate salt and appears as a white to off-white lyophilised powder in solid form. The free acid is the pharmacologically relevant species, while the counter-ion improves handling and dissolution.
| Property | Value | Notes |
|---|---|---|
| Primary receptor target | MC4R | Highest reported agonist potency within the family |
| Secondary receptor activity | MC1R and MC3R | Lower potency than at MC4R |
| Elimination half-life | About 2 to 3 hours | Measured after subcutaneous administration |
| Plasma protein binding | Approximately 44 percent | Species- and assay-dependent |
| Route of administration | Subcutaneous injection | Reviewed product uses a single-use device |
Bremelanotide is a synthetic cyclic heptapeptide that acts on a family of G-protein-coupled receptors. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous peptide associated with pigmentation and several central signalling pathways. A lactam bridge constrains the ring and slows enzymatic breakdown, which distinguishes it from the linear parent molecule. Research interest moved over time from pigment biology toward central nervous system effects, particularly circuits connected to sexual desire. Parenteral delivery is used because oral bioavailability is poor.
Early clinical work used an intranasal formulation, and later programmes switched to subcutaneous delivery for more consistent absorption. A subcutaneous product received regulatory approval in the United States in 2019 for premenopausal women with acquired, generalised hypoactive sexual desire disorder. Approval followed phase 3 trials in which active treatment separated from placebo on desire and distress measures, though the average difference was modest. Labeling carries a caution about transient blood pressure elevation, so cardiovascular history is assessed before prescribing. Questions about durability of benefit beyond several months remain open.
Published discussion sits at the intersection of peptide chemistry, neuroendocrinology and sexual medicine. Trial reports emphasise change scores on validated instruments, while mechanistic papers focus on hypothalamic circuits and receptor selectivity. Because placebo response in this field is large, effect sizes are usually reported with confidence intervals rather than as isolated averages. Reviews note that female and male data sets are not interchangeable and should be read separately. Diagnostic terminology has been revised over time, which complicates comparison between older and newer studies.
Mathematical Biology is a two-part monograph on mathematical biology first published in 1989 by the applied mathematician James D. Murray. It is considered to be a classic in the field and sweeping in scope.
In quantum mechanics and quantum field theory, the vacuum is defined as the state (that is, the solution to the equations of the theory) with the lowest possible energy (the ground state of the Hilbert space). In quantum electrodynamics this vacuum is referred to as 'QED vacuum' to distinguish it from the vacuum of quantum chromodynamics, denoted as QCD vacuum. QED vacuum is a state with no matter particles (hence the name), and no photons. As described above, this state is impossible to achieve experimentally. (Even if every matter particle could somehow be removed from a volume, it would be impossible to eliminate all the blackbody photons.) Nonetheless, it provides a good model for realizable vacuum, and agrees with a number of experimental observations as described next. QED vacuum has interesting and complex properties. In QED vacuum, the electric and magnetic fields have zero average values, but their variances are not zero. As a result, QED vacuum contains vacuum fluctuations (virtual particles that hop into and out of existence), and a finite energy called vacuum energy. Vacuum fluctuations are an essential and ubiquitous part of quantum field theory. Some experimentally verified effects of vacuum fluctuations include spontaneous emission and the Lamb shift. Coulomb's law and the electric potential in vacuum near an electric charge are modified. Theoretically, in QCD multiple vacuum states can coexist. The starting and ending of cosmological inflation is thought to have arisen from transitions between different vacuum states.
14 June Vodafone and Three announce a merger, pending approval from regulators, to create the largest mobile company in the UK. Thousands of people gather for a vigil to mourn the victims of the attacks in Nottingham. Police continue questioning a suspect, as the BBC obtains CCTV footage of a man believed to be the perpetrator. Researchers at the University of Cambridge report the creation of the first synthetic human embryo from stem cells, without the need for sperm or egg cells. 15 June Partygate: A 13-month investigation by the House of Commons' Privileges Committee concludes that ex-Prime Minister Johnson deliberately misled the Commons over gatherings during pandemic restrictions at 10 Downing Street and Chequers. The report proposes that he would be suspended for 90 days if still an MP. It states that he deliberately misled the House and the committee, impugned the committee and was "complicit in the campaign of abuse and attempted intimidation of the Committee". The Parole Board announces that double child killer and rapist Colin Pitchfork has been granted parole and will be released from prison. Alberto Costa, MP for South Leicestershire where the girls were killed, writes to the Justice Secretary to seek "an immediate and urgent review" of the decision. 16 June A hosepipe and sprinkler ban is announced for Kent and Sussex, beginning on 26 June, after water demand hits record levels.
The Fo transmembrane domain is involved in the movement of ions across the membrane. The bacterial FoF1-ATPase consists of the soluble F1 domain and the transmembrane Fo domain, which is composed of several subunits with varying stoichiometry. There are two subunits, γ, and ε, that form the central stalk and they are linked to Fo. Fo contains a c-subunit oligomer in the shape of a ring (c-ring). The α subunit is close to the subunit b2 and makes up the stalk that connects the transmembrane subunits to the α3β3 and δ subunits. F-ATP synthases are identical in appearance and function except for the mitochondrial FoF1-ATP synthase, which contains 7-9 additional subunits. The electrochemical potential is what causes the c-ring to rotate in a clockwise direction for ATP synthesis. This causes the central stalk and the catalytic domain to change shape. Rotating the c-ring causes three ATP molecules to be made, which then causes H+ to move from the P-side (positive-side) of the membrane to the N-side (negative-side) of the membrane. The counterclockwise rotation of the c-ring is driven by ATP hydrolysis and ions move from the N-side to the P-side, which helps to build up electrochemical potential.
Sources: en.wikipedia.org
The ovarian stroma is a unique type of tissue in the ovary that gives structural and metabolic support to the functional parenchyma composed of follicles. The stroma is abundantly supplied with blood vessels, consisting for the most part of spindle-shaped stromal cells. These appear similar to fibroblasts. The stroma also contains ordinary connective tissue such as reticular fibers and collagen. Ovarian stroma differs from typical connective tissue in that it contains a high number of cells. The stromal cells are distributed in such a way that the tissue appears to be whorled. Stromal cells associated with maturing follicles may acquire endocrine function and secrete estrogens. The entire ovarian stroma is highly vascular. On the surface of the organ this tissue is much condensed, and forms a layer (tunica albuginea) composed of short connective-tissue fibers, with fusiform cells between them. The stroma of the ovary contains interstitial cells.
=== DNA chips === Early biochips were based on the idea of a DNA microarray, e.g., the GeneChip DNAarray from Affymetrix, which is a piece of glass, plastic or silicon substrate, on which pieces of DNA (probes) are affixed in a microscopic array. Similar to a DNA microarray, a protein array is a miniature array where a multitude of different capture agents, most frequently monoclonal antibodies, are deposited on a chip surface; they are used to determine the presence and/or amount of proteins in biological samples, e.g., blood. A drawback of DNA and protein arrays is that they are neither reconfigurable nor scalable after manufacture. Digital microfluidics has been described as a means for carrying out Digital PCR.
In 2023, Xi put forward new productive forces, this refers to a new form of productive forces derived from continuous sci-tech breakthroughs and innovation that drive strategic emerging and future industries in a more intelligent information era. Under Xi, China made rapid advances in key technological areas, becoming a world leader in tech such as electric vehicles, lithium batteries and solar panels, as well as emerging as a global leader in artificial intelligence.
Sources: en.wikipedia.org
=== Kava bars === Bars serving kava beverage exist outside of the South Pacific. Kava bars exist in several American cities as social, alcohol-free spaces, with the number increasing to around 180 establishments between 2012 and 2017.
=== Atrial fibrillation === Apixaban is recommended by the National Institute for Health and Clinical Excellence for the prevention of stroke and systemic embolism in people with atrial fibrillation and a CHA2DS2-VASc score ≥ 2. Apixaban may also be considered for men with a CHA2DS2-VASc of 1 after accounting for bleeding risk. Apixaban and other direct oral anticoagulants (DOACs) (dabigatran, edoxaban and rivaroxaban) are at least as effective as warfarin in preventing stroke or systemic embolism in people with atrial fibrillation not caused by moderate-to-severe mitral stenosis or mechanical heart valves. Compared to warfarin, DOACs are associated with a significantly lower risk of intracranial hemorrhage, with apixaban demonstrating both superior efficacy and safety. While data are limited for the use of apixaban in people with severely decreased kidney function and those on hemodialysis, studies are investigating its potential as an alternative to standard therapy, vitamin K antagonists. However, optimal dosing in these populations is yet to be determined.
=== Private industry === Many companies in the private sector have taken up use of open models for their flexibility, greater level of control, opportunities to fine-tune, and lower cost to use. AT&T, Thomson Reuters, Harvey, Nomura Holdings, Goldman Sachs, DoorDash and Accenture are among the companies that have moved at least some of their workload to open models. Some of the reported use cases include software development, specialized tasks such as document review and legal agentic tasks.
Sources: en.wikipedia.org
Reported activity is highest at MC4R, with lower potency at MC1R and MC3R. The MC4R interaction is generally treated as the most relevant to its central effects. Selectivity is not absolute, and activity across the family is dose-dependent.
Indirect evidence from animal studies supports central access, and the proposed mechanism requires it. Direct quantification in humans is limited. How much reaches specific brain regions remains an open question.
Published descriptions give a plasma half-life of roughly two to three hours after subcutaneous administration. Values vary with assay method and study population. The figure is an average rather than a fixed molecular property.
PT-141 was the development code used for bremelanotide during its preclinical and early clinical programme. The peptide is now generally referred to by its international nonproprietary name.